Compounds > dapsone

dapsone and epiroprim

dapsone has been researched along with epiroprim in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (72.73)18.2507
2000's2 (18.18)29.6817
2010's1 (9.09)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Queener, SF1
Bera, S; Mondal, D1
Dankert, W; Hartman, PG; Mehlhorn, H; Then, RL1
Arsenijevic, D; Chang, HR; Comte, R; Pechère, JC; Polak, A; Then, RL1
Foy, J; Steele, P; Walzer, PD; White, M1
Allegra, CJ; Kovacs, JA; Martinez, A1
Angehrn, P; Hartman, PG; Locher, HH; Schlunegger, H; Then, RL1
Brun-Pascaud, M; Chau, F; Derouin, F; Garry, L; Girard, PM; Jacobus, D1
Dhople, AM3

Reviews

2 review(s) available for dapsone and epiroprim

ArticleYear
New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii.
    Journal of medicinal chemistry, 1995, Nov-24, Volume: 38, Issue:24

    Topics: Animals; Drug Design; Humans; Immunosuppression Therapy; Molecular Structure; Opportunistic Infections; Pneumonia, Pneumocystis; Structure-Activity Relationship

1995
Insights of synthetic analogues of anti-leprosy agents.
    Bioorganic & medicinal chemistry, 2019, 07-01, Volume: 27, Issue:13

    Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship

2019

Other Studies

9 other study(ies) available for dapsone and epiroprim

ArticleYear
A pilot study on the efficacy of epiroprim against developmental stages of Toxoplasma gondii and Pneumocystis carinii in animal models.
    Parasitology research, 1995, Volume: 81, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dapsone; Drug Therapy, Combination; Female; Folic Acid Antagonists; Male; Mice; Mice, Inbred Strains; Mice, Nude; Mice, SCID; Pilot Projects; Pneumocystis; Pneumocystis Infections; Pyrimethamine; Rats; Rats, Nude; Sodium Chloride; Sulfadiazine; Toxoplasma; Toxoplasmosis, Animal; Trimethoprim

1995
Activity of epiroprim (Ro 11-8958), a dihydrofolate reductase inhibitor, alone and in combination with dapsone against Toxoplasma gondii.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:8

    Topics: Animals; Dapsone; Drug Synergism; Female; Folic Acid Antagonists; Mice; Toxoplasma; Toxoplasmosis, Animal; Trimethoprim; Uracil

1994
Synergistic combinations of Ro 11-8958 and other dihydrofolate reductase inhibitors with sulfamethoxazole and dapsone for therapy of experimental pneumocystosis.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:7

    Topics: AIDS-Related Opportunistic Infections; Animals; Dapsone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Folic Acid Antagonists; Immunosuppression Therapy; Male; Pneumonia, Pneumocystis; Rats; Rats, Sprague-Dawley; Sulfamethoxazole; Trimethoprim

1993
Efficacy of epiroprim (Ro11-8958), a new dihydrofolate reductase inhibitor, in the treatment of acute Toxoplasma infection in mice.
    The American journal of tropical medicine and hygiene, 1996, Volume: 54, Issue:3

    Topics: Acute Disease; Administration, Oral; Animals; Anti-Infective Agents; Antiprotozoal Agents; Dapsone; Drug Therapy, Combination; Folic Acid Antagonists; Half-Life; Humans; Injections, Intraperitoneal; Injections, Subcutaneous; Mice; Mice, Inbred BALB C; Sulfadiazine; Toxoplasmosis, Animal; Trimethoprim

1996
Antibacterial activities of epiroprim, a new dihydrofolate reductase inhibitor, alone and in combination with dapsone.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:6

    Topics: Animals; Dapsone; Drug Combinations; Folic Acid Antagonists; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Microbial Sensitivity Tests; Sepsis; Trimethoprim

1996
Combination of PS-15, epiroprim, or pyrimethamine with dapsone in prophylaxis of Toxoplasma gondii and Pneumocystis carinii dual infection in a rat model.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Dapsone; Drug Therapy, Combination; Folic Acid Antagonists; Immunosuppression Therapy; Pneumocystis Infections; Proguanil; Pyrimethamine; Rats; Rats, Wistar; Tetrahydrofolate Dehydrogenase; Toxoplasma; Toxoplasmosis, Animal; Trimethoprim

1996
In vitro activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with brodimoprim and dapsone, against Mycobacterium leprae.
    International journal of antimicrobial agents, 1999, Volume: 12, Issue:4

    Topics: Cell-Free System; Dapsone; Folic Acid Antagonists; Leprostatic Agents; Microbial Sensitivity Tests; Mycobacterium leprae; Trimethoprim

1999
Antimicrobial activities of dihydrofolate reductase inhibitors, used singly or in combination with dapsone, against Mycobacterium ulcerans.
    The Journal of antimicrobial chemotherapy, 2001, Volume: 47, Issue:1

    Topics: Anti-Bacterial Agents; Dapsone; Drug Therapy, Combination; Folic Acid Antagonists; Humans; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Tetrahydrofolate Dehydrogenase; Trimethoprim

2001
In vivo activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with dapsone, against Mycobacterium leprae.
    International journal of antimicrobial agents, 2002, Volume: 19, Issue:1

    Topics: Administration, Oral; Animals; Armadillos; Dapsone; Drug Synergism; Female; Folic Acid Antagonists; Leprostatic Agents; Mice; Mice, Inbred BALB C; Mycobacterium leprae; Trimethoprim

2002